Latest UK venture capital funding rounds and analysis.
Stablepharma Secures £1.7m to Advance Fridge-Free Vaccine Technology at £47m Valuation
Stablepharma Limited, a Bristol-based biopharmaceutical company at the forefront of developing thermostable, fridge-free vaccines and pharmaceutical products, has successfully raised £1.7m in its late...
Ducentis Biotherapeutics Secures £5.9m to Advance Inflammatory Disease Therapies
Ducentis Biotherapeutics Ltd., a Bristol-based preclinical-stage biotechnology company, has successfully raised £5.9m in its latest funding round. The funding, with an allotment date of 20 April 2026 ...
Phast Limited Secures £500k Funding to Advance Bioplastic Innovations
Phast Limited, a biotechnology company based in Sheffield, has successfully raised £500,000 in a recent funding round, achieving an estimated post-money valuation of £2.5 million. The funding, with an...
Preqlinic Limited Secures £75k Funding Round at £2.3m Valuation to Streamline Preclinical Biotech Processes
Preqlinic Limited, a London-based company leveraging AI-enabled technology and human expertise to streamline the preclinical process for biotech firms, has successfully raised £75k in a new funding ro...
Molomix Bioscience Secures £42k Funding to Advance Diagnostic-as-a-Service Model
Molomix Bioscience Limited, a biotechnology company based in Bridgend, has successfully raised £42k in a recent funding round, achieving an estimated post-money valuation of £842k. The funding, formal...
Gaba Labs Secures Nearly £500k to Advance Alcohol Alternatives
Gaba Labs Ltd, a Hemel Hempstead-based innovator in functional ingredients and beverages, has successfully raised £499.7k in its latest funding round. The company specialises in developing alcohol alt...
Resurrect Bio Secures Additional £1.6m in Series A Funding to Advance Sustainable Crop Protection
London-based agricultural biotechnology firm Resurrect Bio Ltd has announced a further Series A funding round, securing £1.6m. The investment, filed on 27 April 2026 with an allotment date of 17 April...
Matoke Holdings Secures £437.6k to Advance Antimicrobial Wound Care Technology
Matoke Holdings Limited, a British biotechnology company based in Southmoor, has successfully raised £437.6k in its latest funding round. The allotment date for this capital injection was 13 March 202...
Galvani Bioelectronics Secures £5.3m to Advance Bioelectronic Medicines
Galvani Bioelectronics Limited, a Stevenage-based medical research company dedicated to developing bioelectronic medicines, has successfully raised £5.3 million in its latest funding round. The allotm...
Neuronostics Secures £2.5m to Advance Neurological Diagnostics
Neuronostics Limited, a Bristol-based medical technology company specialising in digital biomarkers for neurological conditions, has successfully secured £2.5m in its latest funding round. The filing ...
Weatherden Limited Secures £74.5k in Latest Funding Round Amidst Evolving UK Biotech Landscape
Weatherden Limited, an Oxford-based specialist in clinical development consulting, has announced a recent funding round totalling £74.5k. The capital was allotted on 16 March 2026, with the filing dat...
Reo Therapeutics Secures £170k in Early-Stage Funding
Reo Therapeutics Limited, a London-based biotechnology firm, has successfully raised £170k in a recent funding round. The capital infusion, with an allotment date of 25 March 2026 and filing on 23 Apr...
Mosaic Therapeutics Secures £261.4k Growth Funding Amidst Evolving UK Biotech Landscape
Mosaic Therapeutics Limited, an oncology therapeutics company based in Babraham, has successfully secured £261.4k in a recent growth funding round. The funding, with an allotment date of 5 December 20...
Symphorna Limited Secures £3.1m Seed Funding to Advance Multi-Target RNA Therapeutics
Symphorna Limited, a Cambridge-based biotechnology company pioneering multi-target RNA medicines, has successfully closed a seed funding round, raising £3.1m. This investment values the company at an ...
Sonotarg Limited Secures £374.7k to Advance Targeted Cancer Therapies, Reaching £20.2m Valuation
Belfast-based biotechnology firm Sonotarg Limited, a pioneer in innovative microbubble and ultrasound technologies for cancer treatment, has successfully closed a new funding round, raising £374.7k. T...
Cancertain Limited Secures £2.2m to Advance Personalised Cancer Treatment
Cancertain Limited, a UK-based innovator in personalised cancer diagnostics, has successfully raised £2.2m in a recent funding round. The Cheadle-incorporated company, with its headquarters in Manches...
Bionome Holdings Limited Secures £442.7k in Latest Funding Round, Valued at £20.9m
Bionome Holdings Limited, a London-based company engaged in biotechnology research and experimental development alongside environmental consulting activities, has successfully secured £442.7k in its l...
Bioorbit Ltd Secures £10.5m Seed Funding to Advance Space-Based Biologics Manufacturing
Bioorbit Ltd, a pioneering UK-based biotech Contract Development and Manufacturing Organisation (CDMO), has successfully closed a substantial £10.5m seed funding round. The London-headquartered compan...
Cytotrait Limited Secures £3.4m Seed Funding to Advance Crop Technology
Cytotrait Limited, a Manchester-based biotechnology company, has successfully closed a £3.4m seed funding round. The company specialises in developing novel traits for food and agriculture through its...
Glycanage Ltd Secures £566k Funding to Advance Biological Age Testing
Glycanage Ltd, a Newcastle upon Tyne-based biotechnology company specialising in biological age testing, has successfully secured £566,000 in a recent funding round. The capital infusion, with an allo...
Fluidic Sciences Secures £3m to Advance Microfluidic Protein Analysis Platforms
Fluidic Sciences Limited, a Royston based developer of microfluidic instruments, has raised an estimated £3m in new funding. The allotment, filed today, brings the company to an estimated post-money v...
Fermentation Technologies Secures £2.5m to Advance Animal-Free Proteins
Oxford-based Fermentation Technologies Ltd, operating under the name Fermtech, has secured £2.5m in a new funding round to scale its sustainable food ingredient production. The company specialises in ...
Accession Therapeutics secures £5.7m to advance targeted cancer immunotherapies
Oxford-based biopharmaceutical company Accession Therapeutics Limited has raised £5.7m in a new funding round, achieving a post-money valuation of £75.6m. The allotment was finalised on 18 March 2026,...
Presentient Technologies Secures £427.5k to Accelerate AI Driven Clinical Trial Analysis
London based Presentient Technologies Ltd has raised an estimated £427.5k in new equity funding to further develop its artificial intelligence platform for the biopharmaceutical industry. The latest i...
Biores Ltd Secures £100k Early-Stage Funding to Advance Biotechnology Research
London-based biotechnology research firm Biores Ltd has secured £100k in early-stage funding. The allotment, finalised on March 25, 2026, and filed the following day, values the year-old company at an...
Recircle Limited Secures £625k to Advance Rubber Waste Recycling Technology
Recircle Limited, a London-based industrial biotechnology company, has raised £625k in a new funding round, reaching an estimated post-money valuation of £4m. The company specialises in sustainability...
Sequential Skin Ltd Secures £6.1m Seed Round to Advance Microbiome Testing Platform
London-based biotech startup Sequential Skin Ltd has closed a £6.1m seed funding round, achieving a post-money valuation of £23.6m. The allotment was finalised on March 18, 2026, with the official fil...
Quantified Imaging Limited secures £246.4k pre-seed to advance MRI software for brain disorders
Quantified Imaging Limited, a London-based biotechnology and health tech startup, has raised £246.4k in a pre-seed funding round. The investment gives the early-stage company an estimated post-money v...
Oribiotech Ltd Secures £10.8k in Latest Funding Round
London-based biotechnology manufacturing specialist Oribiotech Ltd has finalized a £10.8k pre-seed funding round, reaching an estimated post-money valuation of £17.2m. The transaction was officially f...
Solstice Oncology Secures £28m Series C+ to Advance Novel Cancer Therapy
Solstice Oncology UK Limited, a newly formed biotechnology company based in Altrincham, has raised £28m in a Series C+ funding round. The allotment, which took place on February 20, 2026, and was file...
Know about a funding round?
If you have a tip about a UK startup raising capital, we want to hear about it.
Submit a Story